Process, optimization, and characterization of budesonide-loaded nanostructured lipid carriers for the treatment of inflammatory bowel disease

References

• Patel MM. Micro/nano-particulate drug delivery systems: a boon for the treatment of inflammatory bowel disease. Expert Opin Drug Deliv. 2016;13:771–775.
   PubMed Web of Science ®Google Scholar
• Kaplan GG. The global burden of IBD: from 2015 to 2025. Nat Rev Gastroenterol Hepatol. 2015;12:720–727.
   PubMed Web of Science ®Google Scholar
• Collnot EM, Ali H, Lehr CM. Nano- and microparticulate drug carriers for targeting of the inflamed intestinal mucosa. J Control Release. 2012;161:235–246.
   PubMed Web of Science ®Google Scholar
• Podolsky DK. Inflammatory bowel disease. N Engl J Med. 2002;347:417–429.
   PubMed Web of Science ®Google Scholar
• Meissner Y, Lamprecht A. Alternative drug delivery approaches for the therapy of inflammatory bowel disease. J Pharm Sci. 2008;97:2878–2891.
   PubMed Web of Science ®Google Scholar
• Moulari B, Béduneau A, Pellequer Y, et al. Lectin-decorated nanoparticles enhance binding to the inflamed tissue in experimental colitis. J Control Release. 2014;188:9–17.
   PubMed Web of Science ®Google Scholar
• Nakase H, Okazaki K, Tabata Y, et al. An oral drug delivery system targeting immune-regulating cells ameliorates mucosal injury in trinitrobenzene sulfonic acid-induced colitis. J Pharmacol Exp Ther. 2001;297:1122–1128.
   PubMed Web of Science ®Google Scholar
• Lamprecht A, Ubrich N, Yamamoto H, et al. Biodegradable nanoparticles for targeted drug delivery in treatment of inflammatory bowel disease. J Pharmacol Exp Ther. 2001;299:775–781.
   PubMed Web of Science ®Google Scholar
• Lamprecht A. IBD: selective nanoparticle adhesion can enhance colitis therapy. Nat Rev Gastroenterol Hepatol. 2010;7:311–312.
   PubMed Web of Science ®Google Scholar
• Laroui H, Dalmasso G, Nguyen HT, et al. Drug-loaded nanoparticles targeted to the colon with polysaccharide hydrogel reduce colitis in a mouse model. Gastroenterology. 2010;138:843–853 (e841–842).
   PubMed Web of Science ®Google Scholar
• Lamprecht A, Schafer U, Lehr CM. Size-dependent bioadhesion of micro- and nanoparticulate carriers to the inflamed colonic mucosa. Pharm Res. 2001;18:788–793.
   PubMed Web of Science ®Google Scholar
• Lamprecht A, Yamamoto H, Takeuchi H, et al. Nanoparticles enhance therapeutic efficiency by selectively increased local drug dose in experimental colitis in rats. J Pharmacol Exp Ther. 2005;315:196–202.
   PubMed Web of Science ®Google Scholar
• Nakase H, Okazaki K, Tabata Y, et al. Development of an oral drug delivery system targeting immune-regulating cells in experimental inflammatory bowel disease: a new therapeutic strategy. J Pharmacol Exp Ther. 2000;292:15–21.
   PubMed Web of Science ®Google Scholar
• Beloqui A, Coco R, Alhouayek M, et al. Budesonide-loaded nanostructured lipid carriers reduce inflammation in murine DSS-induced colitis. Int J Pharm. 2013;454:775–783.
   PubMed Web of Science ®Google Scholar
• Chopra A, Pardi DS, Loftus EV Jr, et al. Budesonide in the treatment of inflammatory bowel disease: the first year of experience in clinical practice. Inflamm Bowel Dis. 2006;12:29–32.
   PubMed Web of Science ®Google Scholar
• Makhlof A, Tozuka Y, Takeuchi H. pH-Sensitive nanospheres for colon specific drug delivery in experimentally induced colitis rat model. Eur J Pharm Biopharm. 2009;72:1–8.
   PubMed Web of Science ®Google Scholar
• Klotz U, Schwab M. Topical delivery of therapeutic agents in the treatment of inflammatory bowel disease. Adv Drug Deliv Rev. 2005;57:267–279.
   PubMed Web of Science ®Google Scholar
• Yang YX, Lichtenstein GR. Corticosteroids in Crohn's disease. Am J Gastroenterol. 2002;97:803–823.
   PubMed Web of Science ®Google Scholar
• Patel MM, Amin AF. Process, optimization and characterization of mebeverine hydrochloride loaded guar gum microspheres for irritable bowel syndrome. Carbohydr Polym. 2011;86:536–545.
   Web of Science ®Google Scholar
• Chourasia MK, Jain SK. Design and development of multiparticulate system for targeted drug delivery to colon. Drug Deliv. 2004;11:201–207.
   PubMed Web of Science ®Google Scholar
• Lorenzo-Lamosa ML, Remunan-Lopez C, Vila-Jato JL, et al. Design of microencapsulated chitosan microspheres for colonic drug delivery. J Control Release. 1998;52:109–118.
   PubMed Web of Science ®Google Scholar
• Paharia A, Yadav AK, Rai G, et al. Eudragit-coated pectin microspheres of 5-fluorouracil for colon targeting. AAPS PharmSciTech. 2007;8:12.
   PubMed Web of Science ®Google Scholar
• Hua S, Marks E, Schneider JJ, et al. Advances in oral nano-delivery systems for colon targeted drug delivery in inflammatory bowel disease: selective targeting to diseased versus healthy tissue. Nanomedicine. 2015;11:1117–1132.
   PubMed Web of Science ®Google Scholar
• Krishnamachari Y, Madan P, Lin S. Development of pH- and time-dependent oral microparticles to optimize budesonide delivery to ileum and colon. Int J Pharm. 2007;338:238–247.
   PubMed Web of Science ®Google Scholar
• Shete H, Patravale V. Long chain lipid based tamoxifen NLC. Part I: preformulation studies, formulation development and physicochemical characterization. Int J Pharm. 2013;454:573–583.
   PubMed Web of Science ®Google Scholar
• Kasongo KW, Pardeike J, Müller RH, et al. Selection and characterization of suitable lipid excipients for use in the manufacture of didanosine-loaded solid lipid nanoparticles and nanostructured lipid carriers. J Pharm Sci. 2011;100:5185–5196.
   PubMed Web of Science ®Google Scholar
• Chalikwar SS, Belgamwar VS, Talele VR, et al. Formulation and evaluation of nimodipine-loaded solid lipid nanoparticles delivered via lymphatic transport system. Colloids Surf B Biointerfaces. 2012;97:109–116.
   PubMed Web of Science ®Google Scholar
• Triplett MD II, Rathman JF. Optimization of β-carotene loaded solid lipid nanoparticles preparation using a high shear homogenization technique. J Nanopart Res. 2009;11:601–614.
   Web of Science ®Google Scholar
• Neupane YR, Srivastava M, Ahmad N, et al. Lipid based nanocarrier system for the potential oral delivery of decitabine: formulation design, characterization, ex vivo, and in vivo assessment. Int J Pharm. 2014;477:601–612.
   PubMed Web of Science ®Google Scholar
• Gupta Y, Jain A, Jain SK. Transferrin-conjugated solid lipid nanoparticles for enhanced delivery of quinine dihydrochloride to the brain. J Pharm Pharmacol. 2007;59:935–940.
   PubMed Web of Science ®Google Scholar
• Fry DW, White JC, Goldman ID. Rapid separation of low molecular weight solutes from liposomes without dilution. J Anal Biochem. 1978;90:809–807.
   PubMed Web of Science ®Google Scholar
• Nunthanid J, Luangtana-anan M, Sriamornsak P, et al. Use of spray-dried chitosan acetate and ethylcellulose as compression coats for colonic drug delivery: effect of swelling on triggering in vitro drug release. Eur J Pharm Biopharm. 2009;71:356–361.
   PubMed Web of Science ®Google Scholar
• Patel MM, Amin AF. Formulation and development of release modulated colon targeted system of meloxicam for potential application in the prophylaxis of colorectal cancer. Drug Deliv. 2011;18:281–293.
   PubMed Web of Science ®Google Scholar
• Patel MM, Amin AA. Design and optimization of colon targeted system of theophylline for chronotherapy of nocturnal asthma. J Pharm Sci. 2011;100:1760–1772.
   PubMed Web of Science ®Google Scholar
• Patel MM, Amin AF. Development of a novel tablet-in-capsule formulation of mesalamine for inflammatory bowel disease. Pharm Dev Technol. 2013;18:390–400.
   PubMed Web of Science ®Google Scholar
• Patel MM, Patel SL, Bhadani MN, et al. A synchronous colon specific drug delivery system for orally administered mesalamine. Acta Pharm Sci. 2009;51:251–260.
   Google Scholar
• Patel MM, Shah TJ, Amin AF, et al. Design, development and optimization of a novel time and pH-dependent colon targeted drug delivery system. Pharm Dev Technol. 2009;14:65–69.
   Web of Science ®Google Scholar
• Patel MM. Formulation and development of di-dependent microparticulate system for colon-specific drug delivery. Drug Deliv Transl Res. 2017;7:312–324.
   PubMed Web of Science ®Google Scholar
• The International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for HumanUse [Internet]. Available from: www.ich.org
   Google Scholar
• Abdelwahed W, Degobert G, Fessi H. Investigation of nanocapsules stabilization by amorphous excipients during freeze-drying and storage. Eur J Pharm Biopharm. 2006;63:87–94.
   PubMed Web of Science ®Google Scholar
• Hoshimoto A, Suzuki Y, Katsuno T, et al. Caprylic acid and medium-chain triglycerides inhibit IL-8 gene transcription in Caco-2 cells: comparison with the potent histone deacetylase inhibitor trichostatin A. Brit J Pharmcol. 2002;136:280.
   PubMed Web of Science ®Google Scholar
• Kono H, Enomoto N, Connor HD, et al. Medium-chain triglycerides inhibit free radical formation and TNF-alpha production in rats given enteral ethanol. Am J Physiol Gastrointest Liver Physiol. 2000;278:G467–G476.
   PubMed Web of Science ®Google Scholar
• Das S, Ng WK, Tan RB. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs? Eur J Pharm Sci. 2012;47:139–151.
   PubMed Web of Science ®Google Scholar
• Hu L, Tang X, Cui F. Solid lipid nanoparticles (SLNs) to improve oral bioavailability of poorly soluble drugs. J Pharm Pharmacol. 2004;56:1527–1535.
   PubMed Web of Science ®Google Scholar
• Liu J, Hu W, Chen H, et al. Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery. Int J Pharm. 2007;328:191–195.
   PubMed Web of Science ®Google Scholar
• Chavan SS, Ingle SG, Vavia PR. Preparation and characterization of solid lipid nanoparticle-based nasal spray of budesonide. Drug Deliv Transl Res. 2013;3:402–408.
   PubMed Web of Science ®Google Scholar
• Das S, Chaudhury A. Recent advances in lipid nanoparticle formulations with solid matrix for oral drug delivery. AAPS PharmSciTech. 2011;12:62–76.
   PubMed Web of Science ®Google Scholar
• Rowe RC, Sheskey PJ, Quinn ME. Handbook of pharmaceutical excipients. 6th ed. London (UK): Pharmaceutical Press; 2009.
   Google Scholar
• Jose S, Prema MT, Chacko AJ, et al. Colon specific chitosan microspheres for chronotherapy of chronic stable angina. Colloids Surf B Biointerfaces. 2011;83:277–283.
   PubMed Web of Science ®Google Scholar
• Xu J, Bovet LL, Zhao K. Taste masking microspheres for orally disintegrating tablets. Int J Pharm. 2008;359:63–69.
   PubMed Web of Science ®Google Scholar
• Bamba M, Puisieux F, Marty J-P, et al. Release mechanisms in gel forming sustained release preparations. Int J Pharm. 1979;2:307–315.
   Web of Science ®Google Scholar